Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial

NCT07050524 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Stage III

Interventions

DIETARY_SUPPLEMENT: Omega-3 Supplementation
DRUG: Neoadjuvant Immunotherapy

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]
[object Object]
[object Object]